ITMCTR2000003642Not yet recruitingPhase 1
A randomized, double-blind controlled study of Zhichan granules in the treatment of Parkinson's disease
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Not yet recruiting
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Ages
- 40 to 80 (—)
- Sex
- All
Inclusion Criteria
- •(1) Meeting the diagnostic criteria for Parkinson's disease;
- •(2) Aged between 40 and 80 years;
- •(3) Patients with grade 3 or below according to the improved Hoehn-Yahr grading method;
- •(4) Meeting the criteria for diagnosis of TCM syndrome of liver-kidney Yin deficiency or deficiency of qi and blood.
- •(5) TCM syndrome score >= 10.
- •(6) Those who sign the informed consent.
Exclusion Criteria
- •(1) Those who had undergone cell knife surgery in the half year before the experiment;
- •(2) Patients with severe hypertension (blood pressure >180/120), and poor blood pressure?control;
- •(3) Mental illness, epilepsy, pregnant women and lactating women;
- •(4) Patients with severe cerebral arteriosclerosis, cerebrovascular disease and?the resultant limb dysfunction;
- •(5) Patients with severe heart failure, kidney failure, abnormal liver function, bone disease, etc. that affect the evaluation of the curative effect of this disease;
- •(6) Alcoholism, drug addiction or severe mental impairment (including severe alzheimer's disease), thus unable to take drugs on time and cooperating with the examination;
- •(7) Participants in other clinical trials in recent 2 months;
- •(8) Patients with Parkinson's syndrome and Parkinson's superimposed syndrome;
- •(9) Allergic constitution and allergic to known ingredients of test and control drugs.
Investigators
Similar Trials
Recruiting
Phase 1
A randomized double-blind controlled study of Guizhi Decoction in the treatment of early rheumatoid arthritis based on ultrasonic evaluatioRheumatoid arthritisITMCTR2000003615Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Not yet recruiting
Phase 1
A double-blind randomized controlled trial of Qizhi Tongfeng Granule in the treatment of chronic refractory goutITMCTR2200006076Fangshan Hospital Affiliated to Beijing University of Chinese Medicine
Recruiting
Not Applicable
A randomized, double-blind controlled study of the efficacy of infrared-whole body hyperthermia in patients with major depressioF32.1F32.2F33.1F33.2Moderate depressive episodeSevere depressive episode without psychotic symptomsRecurrent depressive disorder, current episode moderateRecurrent depressive disorder, current episode severe without psychotic symptomsDRKS00015754Klinik für Psychiatrie und PsychotherapieCharité Campus Mitte82
Completed
Phase 2
Vitamin D supplementation for the treatment of Behcet's diseaseBehcet's disease.Behçet diseaseIRCT201212216975N4Vice chancellor for research, Tabriz University of Medical Sciences50
Not yet recruiting
Phase 3
A randomized controlled, double-blind study of Chinese medicine combined with EGFR-TKI in the treatment of stage IV EGFR mutation-positive non-small cell lung cancerITMCTR1900002685Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine